EARLY SCD8 PLASMA-LEVELS DURING SUBCUTANEOUS RIL-2 THERAPY IN PATIENTS WITH RENAL-CELL CARCINOMA CORRELATE WITH RESPONSE

Authors
MARTENS A JANSSEN RAJ SLEIJFER DT HEIJN AA MULDER NH THE TH DELEIJ L
Citation
A. Martens et al., EARLY SCD8 PLASMA-LEVELS DURING SUBCUTANEOUS RIL-2 THERAPY IN PATIENTS WITH RENAL-CELL CARCINOMA CORRELATE WITH RESPONSE, British Journal of Cancer, 67(5), 1993, pp. 1118-1121
Citations number
15
Categorie Soggetti
Oncology
Journal title
British Journal of Cancer → ACNP
ISSN journal
00070920
Volume
67
Issue
5
Year of publication
1993
Pages
1118 - 1121
Database
ISI
SICI code
0007-0920(1993)67:5<1118:ESPDSR>2.0.ZU;2-R
Abstract
Plasma sIl-2R and sCD8 levels of 12 patients with renal cell carcinoma were determined before and during subcutaneous rIl-2 therapy. Patient s with a complete/partial remission showed a significantly stronger in itial increase of sCD8 compared to patients with stable disease or tum our progression.